INTECH Investment Management’s Kura Oncology KURA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$218K Sell
19,860
-1,785
-8% -$16.8K ﹤0.01% 1752
2026
Q1
$176K Sell
21,645
-11,265
-34% -$96.8K ﹤0.01% 1789
2025
Q4
$342K Buy
32,910
+4,213
+15% +$44.2K ﹤0.01% 1691
2025
Q3
$254K Sell
28,697
-19,835
-41% -$141K ﹤0.01% 1922
2025
Q2
$280K Sell
48,532
-11,586
-19% -$71K ﹤0.01% 1905
2025
Q1
$397K Buy
60,118
+8,951
+17% +$69.8K ﹤0.01% 1744
2024
Q4
$446K Buy
51,167
+35,910
+235% +$517K ﹤0.01% 1627
2024
Q3
$298K Buy
+15,257
New +$309K ﹤0.01% 1528

Other funds holding KURA

INTECH Investment Management's KURA Position: Q2 2026 in Review

INTECH Investment Management reduced its Kura Oncology (KURA) stake by 8.2% in Q2 2026, selling an estimated $16.8K and leaving 19,860 shares worth $218K. The position accounts for ﹤0.01% of the portfolio, ranked #1752.

INTECH Investment Management first reported a position in KURA in Q3 2024 and has held it in 8 quarters since. The position peaked at $446K in Q4 2024. 221 funds tracked by Wall St. Rank hold KURA as of Q2 2026.

  • INTECH Investment Management held 19,860 shares of Kura Oncology worth $218K as of Q2 2026.
  • INTECH Investment Management sold 1,785 Kura Oncology shares in Q2 2026, an estimated $16.8K.
  • Kura Oncology made up ﹤0.01% of INTECH Investment Management's portfolio in Q2 2026, its #1752 holding.
  • INTECH Investment Management first reported a position in Kura Oncology in Q3 2024 and has held it in 8 quarters since.
  • INTECH Investment Management's Kura Oncology position peaked at $446K in Q4 2024.
  • 221 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.